The objective of this study is to evaluate the benefitS of UMOOZE® as an add-on therapy for BPH.
• UMOOZE® improved the overall score of IPSS nocturia and LUTS (Lower Urinary Tract Symptoms).
• UMOOZE® improved the patients Quality of Life (QoL).
• UMOOZE® decreased the PVR (Post-Void Residual) urine volume.
• UMOOZE® reduced the prostate volume in patients with BPH.
• UMOOZE® as an add-on therapy has proven to be helpful and well-tolerated in BPH patients.
• UMOOZE® as an add-on therapy may offer benefits in the management of BPH.